Stairs research December 2020

Stairs research December 2020

A head and shoulders professional photo of Douglas Stairs against a photo of Penn State Cancer Institute

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State Cancer Institute and Penn State College of Medicine researchers. They said that testing cancers for the presence of this protein may help clinicians identify patients who may be resistant to or relapse when treated with the therapy. 

IMAGE: Penn State